Risk factors for developing tuberculosis: A 12-year follow-up of contacts of tuberculosis cases

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 9, 2010, Pages 1112-1119

  Morán Mendoza, Onofre ^a   Marion, S A ^b   Elwood, K ^b   Patrick, D ^b   FitzGerald, J M ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Epidemiology; Pulmonary; Tuberculosis; Tuberculosis control

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BCG VACCINE; BRITISH COLUMBIA; CHILD; CONTACT TRACING; FAMILY CHARACTERISTICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MALNUTRITION; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 77956567571     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR 1999; 48 (RR-9): 1-13.
2. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-1395.
3. Long R, Ellis E, eds. Canadian tuberculosis standards. 6th ed. Ottawa, ON, Canada: Canadian Lung Association and Public Health Agency of Canada, 2007.
4. American Thoracic Society/Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161 (4 Pt 2): S221-S247.
5. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005; 172: 1169-1227.
6. Enarson D A, Chen-Yuan C, Murray J F. Global epidemiology of tuberculosis. In: Rom W N, Garay S M, eds. Tuberculosis. 2nd ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 2004: pp 13-29.
7. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2002. WHO/CDS/ TB/2002.295. Geneva, Switzerland: WHO, 2002.
8. Marazzi A. Algorithms, routines and S functions for robust statistics. Pacific Grove, CA, USA: Wadsworth & Brooks/Cole, 1992.
9. Chia S, Karim M, Elwood R K, FitzGerald J M. Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis 1998; 2: 989-991.
10. Andrew O T, Schoenfeld P Y, Hopewell P C, Humphreys M H. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: 59-65.
11. Pablos-Mendez A, Blustein J, Knirsch C A. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997; 87: 574-579.
12. Lichtenstein I H, MacGregor R R. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 1983; 5: 216-226.
13. Munoz P, Palomo J, Munoz R, Rodriguez-Creixems M, Pelaez T, Bouza E. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995; 21: 398-402.
14. Korner M M, Hirata N, Tenderich G, et al. Tuberculosis in heart transplant recipients. Chest 1997; 111: 365-369.
15. Feld R, Bodey G P, Groschel D. Mycobacteriosis in patients with malignant disease. Arch Intern Med 1976; 136: 67-70.
16. Kaplan M H, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer 1974; 33: 850-858.
17. Patel K C, Shah D P, Sheth S M, Kamat S R. Association of tuberculosis with malignancy. J Postgrad Med 1977; 23: 193-196.
18. Ferebee S H. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26: 28-106.
19. Edwards L B, Livesay V T, Acquaviva F A, Palmer C E. Height, weight, tuberculous infection, and tuberculous disease. Arch Environ Health 1971; 22: 106-112.
20. Palmer C E, Jablon S, Edwards P Q. Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build. Am Rev Tuberc 1957; 76: 517-539.
21. Ferebee S H, Mount F W. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis 1962; 85: 490-510.
22. Canadian Lung Association, Health and Welfare Canada. Canadian tuberculosis standards. 3rd ed. Ottawa, ON, Canada: Canadian Lung Association, Health and Welfare Canada, 1988.
23. Comstock G W, Livesay V T, Woolpert S F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131-138.
24. Radhakrishna S, Frieden T R, Subramani R. Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in south India: a 15-year follow-up. Int J Tuberc Lung Dis 2003; 7: 1083-1091.
25. Moran-Mendoza O, Marion S A, Elwood K, Patrick D M, Fitzgerald J M. Tuberculin skin test size and risk of tuberculosis development: a large population-based study in contacts. Int J Tuberc Lung Dis 2007; 11: 1014-1020.
26. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
27. Tuberculosis Prevention Trial. Trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 1979: 349-363.
28. Comstock G W, Woolpert S F, Livesay V T. Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep 1976; 91: 276-280.
29. Comstock G W, Livesay V T, Woolpert S F. Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health 1974; 64: 283-291.
30. Colditz G A, Brewer T F, Berkey C S, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
31. Medical Research Council. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull World Health Organ 1972; 46: 371-385.
32. Colditz G A, Berkey C S, Mosteller F, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96: 29-35.